All trials - page: 285

All trials

Displaying of results
Download as CSV
NCTID
Brief title
Sponsor
Design
Criteria
Status
Target enrollment
Study phase & design
Primary intervention type
Primary potential benefit
Outcome measure
Follow up
Start date
First posted
Location
NCT04049994Immunomodulation Therapy for Urinary Tract InfectionsSwiss Paraplegic Research, Nottwil
  • Age 18 - 60 yrs
  • Level C1-S5
  • AIS A, B, C, D
  • 1 months - 3 months
Ended24PHASE4DrugGeneral health01 June 202008 August 20191
NCT04029974Speed of Robotic Leg Movements and Orthostatic Hypotension in Subacute SCIMethodist Rehabilitation Center
  • Age 16 - 70 yrs
  • Level C1-S5
  • AIS C
  • ≤ 12 weeks
Active35NATechnologyGeneral health20 August 201923 July 20191
NCT04008160Intelligent Underwear (IU) in ParaplegicsSwiss Paraplegic Research, Nottwil
  • Age 18 - 50 yrs
  • Level C1-S5
  • AIS A, B, C, D
  • ≤ 50 years
Ended0TechnologySkin health01 October 202205 July 20191
NCT03987126Prebiotics for Spinal Cord Injury Patients With Bowel and Bladder DysfunctionLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
  • Age ≥ 18 yrs
  • Level C1-S5
  • AIS A, B, C, D
  • ≥ 3 months
Ended30PHASE3DrugBowel health27 January 202114 June 20191
NCT03989440AXER-204 in Participants With Chronic Spinal Cord InjuryReNetX Bio, Inc.
  • Age 18 - 65 yrs
  • Level C1-C8
  • AIS A, B, C, D
  • 1 years - 65 years
  • have a spinal cord injury for at least 1 year.
  • have a cervical spinal cord injury.
  • have “serious” neurological deficits in upper extremity motor function (upper extremity motor score between 4-36 out of 50).
  • be between the ages of 18 and 65 years.
Ended52PHASE1, PHASE2DrugGeneral health16 July 201918 June 20196
NCT03965299Transcutaneous Tibial Nerve Stimulation in Acute Spinal Cord InjuryUniversity of Zurich
  • Age ≥ 18 yrs
  • Level C1-T12
  • AIS A, B, C, D
  • ≤ 40 days
Recruiting114NATechnologyBladder health/function19 June 201929 May 20194